Etymologists [Shorter Oxford English Dictionary (1959), 3rd edn., Oxford University Press, Oxford1 tell us that the word 'influenza' is of Italian origin and originally meant a 'visitation' or 'influence' of any epidemic disease. By its application to the 1743 epidemic, it became a name for a specific disease. However, it was not until 1933 that the causative virus was finally isolated by Smith et al. (1933) from man. This breakthrough paved the way for vaccination programmes, but unfortunately these provided only transient immunity lasting 1-2 years. It soon became clear that influenza differed from many other viral diseases in that the virus was continually changing. Thus immunity raised against a given viral strain, or in response to the injection of a killed virus, was of little significance for new strains with altered surface proteins. This recognition of antigenic variation in both the surface haemagglutinin and neuraminidase molecules rationalized the observed epidemiology of the disease. In particular, it explained why all age groups could contract the disease and why infection occurs more than once (Pereira, 1979) .
Antigenic variation
Influenza belongs to the myxo group of RNA-containing viruses, which are sensitive to diethyl ether by virtue of the $ To whom correspondence should be addressed.
presence of the host-derived phospholipid membrane. Three types, specifically types A, B and C, are recognized by their differing internal antigens. Influenza A is the most important clinically, although B strains can and do cause disease. Influenza A strains have been much more intensively studied at the molecular level than have the B and C strains, and this present communication is confined to them. All influenza A strains show the presence of external spikes when viewed under the electron microscope. The two kinds of spikes can be distinguished by various techniques. One is formed from haemagglutinin molecules, the other from neuraminidase molecules, and there are roughly 5 times as many haemagglutinin spikes than neuraminidase spikes (Wrigley, 1979) .
Both the haemagglutinin and the neuraminidase undergo antigenic variation (Webster et al., 1982) , and two types are normally distinguished, although we indicate below that these are merely extremes of the types of molecular variation possible as a result of numerous point mutations. Antigenic shift is a major change in antigenicity, whereas antigenic drift is a minor change, yet still a sufficient one to cause a new epidemic. Pandemics occurred in the human population in 1957 (Asian 'flu) and in 1968 (Hong Kong 'flu) and both correlated with the appearance of significantly antigenically altered haemagglutinin molecules. Thus the antigenic variation of the haemagglutinin is considered to be quantitatively more significant than that of the neuraminidase.
From this introduction, it should be apparent that the molecular biology of influenza variation resolves mainly into a study of the amino acid sequence of the antigenic regions of the haemagglutinin molecule. The first molecular studies were by direct amino acid sequence analysis of the isolated protein.
However, in the last 5 years, nucleotide sequencing of the haemagglutinin RNA gene either directly, or indirectly by molecular cloning and deducing the amino acid sequence from the genetic code, has proved easier and faster.
Structure of haemagglutinin and antigenicity
A study of antigenic shift at the molecular level in man first involved cloning the haemagglutinin gene of representative examples of the human subtypes H1, H2 and H3 (Table l) , known to have caused disease since the first viral isolation. As a result of many authors' work involving cloning and sequencing (e.g. see Webster et al., 1982), we now know that different subtypes all conform to the same generalized organization of a haemagglutinin into an HA1 subunit of approximately 327 amino acid residues linked by a single disulphide bridge to a shorter HA2 subunit of about 221 amino acid residues. But they show surprisingly little detailed amino acid homology when the sequences are aligned vertically (Winter et al., 1981) . Table 2 shows the amino acid homology between H1, H2 and H3 subtypes for their respective HA1 and HA2 subunits. For example, in H1 and H3 subtypes, the haemagglutinin molecule shows only 35% homology in their HA1 subunits. However, cysteine residues and some other structural amino acids are well conserved, suggesting that the three-dimensional structure is maintained despite remarkable variation in amino acid sequence.
An early study of peptide fragments recognized by antihaemagglutinin antibodies suggested that antigenicity is a function of the HA1 subunit (see, e.g., Jackson et al., 1979) . The importance of this domain became even more apparent when the three-dimensional structure became known (Wilson et al., 1981) , as the HA1 subunit corresponds to the globular head of the protein. Nevertheless the extensive molecular evolution does not, by itself allow us to state definitively that amino acid point mutations contribute to antigenicity. Some, or many, changes, one might argue, are not antigenic, and merely reflect a neutral polymorphism. This same criticism can be made against the study of a set of closely related, yet antigenically distinct, 'drifted' naturally occurring variants within a subtype era. Such a study of, for example, the 1968, 1972 and 1975 , 1980; Brownlee, 1981) . Again we may ask: are all these changes antigenic, or merely some of them? To resolve this formally, it is necessary to study single-amino acid variants isolated under antigenic selection in the laboratory.
Laboratory studies of antigenic variation
Laboratory mutants of influenza can easily be isolated by incubating cloned influenza virus with excess antibody. The very small numbers of viruses that escape neutralization can be expanded by injecting the mixture into fertilized eggs. Mutants can then be isolated, their interrelationships studied and the location of the point mutation in the different mutants determined (e.g. see Laver et al., 1979). We have made a detailed and extensive study of 46 laboratory mutants isolated from the parent A/PR/8/34 strain (Caton et al., 1982) . These were isolated with the use of 16 different monoclonal antibodies. As in an earlier, less extensive, study (Gerhard et al., 198 l) , it is possible to group viral mutants according to their reactivity with different groups of antibodies in a solid-phase radioimmune assay, thus defining four antigenic sites Sb, Sa, Ca and Cb on the haemagglutinin (see Table 3 , which shows them in matrix form). These sites are not completely distinct. In particular, there is extensive overlapping between subsites Ca, and Ca, and these may be considered part of the same larger site. Thus four antigenic sites are defined by a radioimmunoassay, the definition of a distinct site being an area to which binding of a panel of specific antibodies remains unaffected by mutations occurring in neighbouring antigenic sites. Clearly a study of the exact amino acid alteration in each of the mutant viruses, characteristic of the antigenic sites, should delimit these sites and perhaps explain the linkage of sites to one another.
Location of amino acid changes in mutant AIPR/8/34
Previously strain. Before studying the mutant forms, the parental A/ PR/8/34 (Mount Sinai) strain was sequenced (Caton et al., 1982) and was shown to differ in 12 nucleotides, including a three-nucleotide deletion in the region coding for the HA1 subunit. One of the changes, the C -+A change at position 469 ( Fig. l) , means that the potential carbohydrate-attachment site at amino acid residue 127 of A/PR/8/34 (Cambridge) strain is absent from A/PR/8/34 (Mount Sinai) strain. Sequencing was performed by the Sanger dideoxynucleotide chain-termination method (Sanger et al., 1977) , modified for analysis of RNA (Caton et al., 1982) . Four synthetic deoxyoligonucleotides were synthesized (Duckworth et al., 198 1) that were complementary to the known haemagglutinin virion RNA and hybridized to it at 200-300-nucleotide-residue intervals (Table 4) . These were used with total virion RNA from the mutant viruses as template and reverse transcriptase to determine the sequence from nucleotide residues 50-1060 covering the entire region coding for the HA1 subunit of the haemagglutinin. The positions of differences in the amino acid residues of 38 unique mutants is marked on Fig. 1 , with details of the nucleotide changes in Table 5 . It can be seen that all occurred in the HA1 subunit domain and covered an extensive region of the primary sequence from amino acid residues 78 to 273 [the residue numbers used here are not the actual numbers in the haemagglutinin of A/PR/8/34 strain but are the equivalent H3 numbers based on alignment with the sequence of subtype H3 (Winter et al., 1981) so as to facilitate location onto the three-dimensional structure].
Antigenic sites on the three-dimensional structure
Assuming that the A/PR/8/34-strain (H 1 -subtype) haemagglutinin has the same three-dimensional architecture as the H3 subtype analysed by Wilson et al. and trimer respectively. They must be viewed with stereo glasses, which are obtainable from an optician or scientific supplier.
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The Sa site (m) forms the front of the upper part of the globular head in Fig. 2 , and it is immediately clear why residues 128 and 129 are part of the same antigenic site as are residues 158, 160, 162, 163, 165, 166 and 167. Residue 164 points inwards, and this is presumably why no mutant was observed at this position. The Sb site (+) occupies the top and back of the globular head in Fig. 2 , and includes the external residues 192, 193 and 196 of an a-helical region as well as residue 198 and residues 156 and 159. Residue 159 is particularly interesting, as it points backwards and is located in the Sb site, whereas the adjacent residues 158 and 160 point forwards, and as already mentioned are part of the Sa site.
The Cb site (0) lies on the left (as seen in Fig. 2 ) and near the base of the globular head, and is defined by mutations at positions 78, 79,81,82 and 83, as well as residue 122, which lies reasonably close (Fig. 2) . w n n w l -I -I -w n n n n n * n n n n n n * n
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The Ca, and Ca, subsites, which show obvious linkage to one another (Table 3) , occupy two widely scattered areas on the three-dimensional structure of the monomer. The Ca, subsite (b) consists of residues 169, 173, 207 and 240, whereas the Ca, subsite (I) comprises residues 140, 143 and 145 as well as residues 224 and 225. The close linkage of subsites Ca, and Ca, occurs because these subsites form a 'cleft' between adjacent monomers in the trimeric structure (Fig. 3) . This cleft thus becomes the fourth antigenic site.
Discussion
We have defined four reasonably discrete areas on the surface of the haemagglutinin where point mutations alter the binding of the mutant virus to a monoclonal antibody. The fact that the point mutations are clustered suggests that they exert their effect directly on the site to which the antibody binds rather than indirectly, for example by acting at a distance and causing a drastic conformational change in the protein. The observed operational linkage (Table 3 ) of sites Sa and Sb is also explained by their close proximity on the surface of the globular head of the protein. It is instructive to consider what the extent of interpction of the haemagglutinin might be with all possible antibody molecules. Only then could we have a complete description of the antigenicity of the molecule. It seems reasonable to assume that, were further mutants isolated, using the rarer antibodies we would start to identify further positions . showing amino acid variation. It seems possible that our four antigenic sites would 'enlarge' and merge into one another, perhaps covering all external residues of the globular head. If so, one might suggest that the real antigenic properties of this molecule can best be explained as a continuum of external residues within which are the four dominant regions defined in this study. The majority of antibody molecules would react with these four regions, but a minority might interact or have part contact with the intervening continuum.
Sign$cance of four dominant antigenic sites
The laboratory studies clearly define antigenic sites detected in the laboratory experiments. It is of interest to compare them with the evolution of field strains of H1 sybtype to reinforce these conclusions and to guard against their being some form of laboratory artifact. Preliminary results on the evolution of the re-emerged H1 subtype for 1977-1981 (F. L. Raymond, A. J. Caton, N. Cox, A. P. Kendal & G. G. Brownlee, unpublished work) suggest that at least some of these sites are significant in the field and that a change in at least one site is necessary for a new epidemiologically significant strain to evolve.
We have also compared the antigenic sites of influenza A/PR/8/34 strain studied here with the four antigenic sites proposed for the Hong Kong H 3 subtype (see Wiley et al., 198 1, (Table 6 ). Sites Sa and Cb of A/PR/8/34 strain and the C site of the Hong Kong 'flu strain lack counterparts in the other subtype. This curious and unexpected feature can be easily explained if we assume that carbohydrate side chains attached to the Asn-Xaa-(Ser or Thr) residues are capable of masking amino acids that would otherwise contribute to the antigenic sites. It is clear from the position of carbohydrate (Table 6 ) that their presence exactly correlates with the position of the missing antigenic site.
Conclusion
A definitive statement of the antigenicity of the haemagglutinin of influenza A/PR/8/34 strain can now be made from the results of laboratory experiments. There are four moreor-less distinct sites on the top of, or surrounding, the globular head. We cannot yet extrapolate these findings to the evolution of the influenza virus in the field, but are hoping to understand something of this from a study of recent H1 variants occurring during 1977-1 98 1, However, we do suggest that carbohydrate masking contributes to alterations in antigenicity between H 1 and H3 subtypes. Clearly carbohydrate location has an important indirect effect on antigenicity. Perhaps the least satisfying conclusion from the practical viewpoint is that the extensive nature of the antigenic regions makes it unlikely that we can either predict future evolution of the influenza virus or design a universal influenza vaccine by virtue of there being a conserved antigenic site. The molecule seems to retain a vast potential for antigenic variation without jeopardizing its function. Perhaps the route to treatment of influenza lies with interferon prophylaxis or by the use of drugs targeted at the specific influenza-RNAdependent RNA-transcription machinery once this becomes better understood at the molecular level.
